{"chunk_id": "medquad__chunk_23856", "source": "medquad", "text": "ebrotendinous xanthomatosis is diagnosed by a combination of clinical features, cholestanol levels, and genetic testing. Individuals with cerebrotendinous xanthomatosis have high levels of cholestanol in their blood. Genetic testing of the CYP27A1 gene is also available and can detect mutations in about 98% of patients.\",GARD,Cerebrotendinous xanthomatosis\nWhat are the treatments for Cerebrotendinous xanthomatosis ?,\"How might cerebrotendinous xanthomatosis be treated? Cerebrotendinous xanthomat"}